Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 11 Feb 2021 |
2 | Reply to Exam Report (MIS-R) | 04 Mar 2021 |
3 | TM-O(NOTICE OF OPPOSITION) | 18 Aug 2022 |
4 | Journal Copy | 26 Aug 2022 |
5 | Hearing Notice | 17 Oct 2023 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 21 Nov 2023 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 Nov 2023 |
8 | Hearing Notice | 04 Jul 2024 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 26 Aug 2024 |
1 | EXAMINATION REPORT | 11154495 | 22 Feb 2021 | |
2 | Hearing Notice (Show Cause) | 13095440 | 28 Feb 2022 | |
3 | Tribunal Accepted Notice for : 4858203 | 13680361 | 5639120 | 21 Jun 2022 |
4 | Opposition Notice | 14228263 | 5742416 | 17 Oct 2022 |
Novel d3 was applied on 11 February 2021.
Trademark application was filed by LYRUS LIFE SCIENCES.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Novel d3 is 4858203.
Trademark attorney of the Novel d3 is Sudeshna Banerjee.
Novel d3 is a WORD as per IP India data.